Argyrios N Theofilopoulos

Summary

Affiliation: The Scripps Research Institute
Country: USA

Publications

  1. ncbi Intracellular nucleic acid sensors and autoimmunity
    Argyrios N Theofilopoulos
    Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California 92137, USA
    J Interferon Cytokine Res 31:867-86. 2011
  2. ncbi TLRs and IFNs: critical pieces of the autoimmunity puzzle
    Argyrios N Theofilopoulos
    Department of Immunology and Microbial Science, Scripps Research Institute, La Jolla, California 92037, USA
    J Clin Invest 122:3464-6. 2012
  3. ncbi The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity
    A N Theofilopoulos
    The Scripps Research Institute, Department of Immunology IMM3, La Jolla, CA 92037, USA
    Arthritis Res 3:136-41. 2001
  4. ncbi Sensors of the innate immune system: their link to rheumatic diseases
    Argyrios N Theofilopoulos
    Department of Immunology and Microbial Science, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
    Nat Rev Rheumatol 6:146-56. 2010
  5. ncbi Type I interferons (alpha/beta) in immunity and autoimmunity
    Argyrios N Theofilopoulos
    Immunology Department, The Scripps Research Institute, La Jolla, California 92037, USA
    Annu Rev Immunol 23:307-36. 2005
  6. ncbi Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
    Dwight H Kono
    Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA
    Proc Natl Acad Sci U S A 106:12061-6. 2009
  7. ncbi The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation
    M Katarina Haraldsson
    Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA
    Immunity 28:40-51. 2008
  8. ncbi Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor
    Dwight H Kono
    Department of Immunology IMM3, The Scripps Research Institute, 10550 N Torrey Pines Road, La Jolla, CA 92037, USA
    Autoimmunity 36:503-10. 2003
  9. ncbi Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice
    Djemel Ait-Azzouzene
    Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Immunol 185:1015-27. 2010
  10. ncbi Paucity of V-D-D-J rearrangements and VH replacement events in lupus prone and nonautoimmune TdT-/- and TdT+/+ mice
    Lisa C Watson
    The Scripps Research Institute, Department of Immunology, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
    J Immunol 177:1120-8. 2006

Research Grants

  1. TYPE I INTERFERONS IN LUPUS
    Argyrios N Theofilopoulos; Fiscal Year: 2010
  2. GENETIC BASIS OF SYSTEMIC AUTOIMMUNITY
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2002
  3. CELL CYCLE AND APOPTOSIS GENES IN IMMUNOLOGIC SENESCENCE
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2002
  4. MURINE MODELS OF GENERALIZED AUTOIMMUNITY
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2001
  5. T Cell Homeostasis in Systemic Autoimmunity
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2006
  6. T Cell Homeostasis in Systemic Autoimmunity
    Argyrios N Theofilopoulos; Fiscal Year: 2010
  7. TYPE I INTERFERONS IN LUPUS
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2009
  8. T Cell Homeostasis in Systemic Autoimmunity
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2009
  9. GENETIC BASIS OF SYSTEMIC AUTOIMMUNITY
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2007
  10. TYPE I INTERFERONS IN LUPUS
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2007

Collaborators

Detail Information

Publications43

  1. ncbi Intracellular nucleic acid sensors and autoimmunity
    Argyrios N Theofilopoulos
    Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California 92137, USA
    J Interferon Cytokine Res 31:867-86. 2011
    ..Evidence, as reviewed here, strongly indicates that these sensors are primary contributors to autoimmune disease pathogenesis, spearheading efforts toward development of novel therapeutics for these disorders...
  2. ncbi TLRs and IFNs: critical pieces of the autoimmunity puzzle
    Argyrios N Theofilopoulos
    Department of Immunology and Microbial Science, Scripps Research Institute, La Jolla, California 92037, USA
    J Clin Invest 122:3464-6. 2012
    ..These insights will permit the development of novel treatment modalities for these disorders...
  3. ncbi The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity
    A N Theofilopoulos
    The Scripps Research Institute, Department of Immunology IMM3, La Jolla, CA 92037, USA
    Arthritis Res 3:136-41. 2001
    ....
  4. ncbi Sensors of the innate immune system: their link to rheumatic diseases
    Argyrios N Theofilopoulos
    Department of Immunology and Microbial Science, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
    Nat Rev Rheumatol 6:146-56. 2010
    ..These findings have resulted in a critical reappraisal of pathogenetic mechanisms, and provide a basis for the development of novel diagnostic and therapeutic modalities for these diseases...
  5. ncbi Type I interferons (alpha/beta) in immunity and autoimmunity
    Argyrios N Theofilopoulos
    Immunology Department, The Scripps Research Institute, La Jolla, California 92037, USA
    Annu Rev Immunol 23:307-36. 2005
    ....
  6. ncbi Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
    Dwight H Kono
    Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA
    Proc Natl Acad Sci U S A 106:12061-6. 2009
    ..Importantly, this helps provide an explanation for the high frequency of anti-nucleic acid Abs in lupus-like systemic autoimmunity...
  7. ncbi The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation
    M Katarina Haraldsson
    Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA
    Immunity 28:40-51. 2008
    ..Our results demonstrate that Coronin-1A is required for the development of systemic lupus and identify actin-cytoskeleton regulatory proteins as potential targets for modulating autoimmune diseases...
  8. ncbi Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor
    Dwight H Kono
    Department of Immunology IMM3, The Scripps Research Institute, 10550 N Torrey Pines Road, La Jolla, CA 92037, USA
    Autoimmunity 36:503-10. 2003
    ..These findings strongly support the targeting of IFN-alphabeta in SLE and suggest that definition of the specific pathways critical for disease induction will be important for optimal intervention...
  9. ncbi Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice
    Djemel Ait-Azzouzene
    Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Immunol 185:1015-27. 2010
    ....
  10. ncbi Paucity of V-D-D-J rearrangements and VH replacement events in lupus prone and nonautoimmune TdT-/- and TdT+/+ mice
    Lisa C Watson
    The Scripps Research Institute, Department of Immunology, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
    J Immunol 177:1120-8. 2006
    ....
  11. ncbi Deficiency of the cyclin kinase inhibitor p21(WAF-1/CIP-1) promotes apoptosis of activated/memory T cells and inhibits spontaneous systemic autoimmunity
    Brian R Lawson
    Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Exp Med 199:547-57. 2004
    ..Thus, modulation of the cell cycle pathway may be a novel approach to reduce apoptosis-resistant pathogenic lymphocytes and to ameliorate systemic autoimmunity...
  12. ncbi An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence
    Michael Berger
    Department of Genetics, The Scripps Research Institute, La Jolla, California, USA
    Nat Immunol 11:335-43. 2010
    ..Our findings identify a physiological role for Slfn2 in the defense against pathogens through the regulation of quiescence in T cells and monocytes...
  13. ncbi The Lbw2 locus promotes autoimmune hemolytic anemia
    John C Scatizzi
    Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Immunol 188:3307-14. 2012
    ..Delineation of the Lbw2 genes should yield new insights into both the pathogenesis of AIHA and the nature of epistatic interactions of lupus-modifying genetic variants...
  14. ncbi Autoimmune alterations induced by the New Zealand Black Lbw2 locus in BWF1 mice
    Maria K Haraldsson
    Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Immunol 174:5065-73. 2005
    ..These findings establish the importance of Lbw2 in the BWF1 hybrid and indicate that Lbw2, by enhancing B cell hyperactivity, promotes the early polyclonal activation of B cells and subsequent production of autoantibodies...
  15. ncbi TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
    Roberto Baccala
    The Scripps Research Institute, Department of Immunology, La Jolla, California 93037, USA
    Nat Med 13:543-51. 2007
    ....
  16. ncbi Sensors of the innate immune system: their mode of action
    Roberto Baccala
    Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA
    Nat Rev Rheumatol 5:448-56. 2009
    ..Although this sensing is beneficial to the host, excessive activation and/or engagement by self molecules might induce autoimmune and other inflammatory disorders...
  17. ncbi Systemic autoimmunity and lymphoproliferation are associated with excess IL-7 and inhibited by IL-7Rα blockade
    Rosana Gonzalez-Quintial
    Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, United States of America
    PLoS ONE 6:e27528. 2011
    ....
  18. ncbi Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives
    Roberto Baccala
    Department of Immunology, IMM 3, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
    Springer Semin Immunopathol 27:75-85. 2005
    ..In its simplicity, this approach is likely to have application in humans, since it relies on conventional lymphopenia-inducing cancer therapies, infusion of autologous lymphocytes and, optimally, tumor-specific vaccination...
  19. ncbi Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice
    Marie Laure Santiago-Raber
    Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Exp Med 197:777-88. 2003
    ..The data indicate that type-I IFNs are important mediators in the pathogenesis of murine lupus, and that reducing their activity in the human counterpart may be beneficial...
  20. ncbi T cell homeostatic proliferation elicits effective antitumor autoimmunity
    Wolfgang Dummer
    Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA
    J Clin Invest 110:185-92. 2002
    ..The results indicate that concomitant induction of the physiologic processes of homeostatic T cell proliferation and tumor antigen presentation in lymph nodes triggers a beneficial antitumor autoimmune response...
  21. ncbi Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery
    Michael J Barnes
    Department of Genetics, The Scripps Research Institute, La Jolla, CA, USA
    PLoS Biol 7:e51. 2009
    ..Furthermore, we show that peripheral T(reg) cells are a dynamic population that may expand to limit immunopathology or promote chronic infection...
  22. ncbi Terminal deoxynucleotidyltransferase deficiency decreases autoimmune disease in diabetes-prone nonobese diabetic mice and lupus-prone MRL-Fas(lpr) mice
    Ian F Robey
    Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Immunol 172:4624-9. 2004
    ..We suggest that the paucity of autoreactive specificities created in the N region-lacking repertoire, and the resultant protection afforded to the newborn, may be the reason that TdT expression is delayed in ontogeny...
  23. ncbi Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed mice
    Roberto Baccala
    Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Immunol 189:5976-84. 2012
    ..The combined findings suggest that IFN-α/β receptor blockade, particularly when started at early disease stages, may be a useful treatment approach for human systemic lupus erythematosus and other autoimmune syndromes...
  24. ncbi Gamma delta T cell homeostasis is controlled by IL-7 and IL-15 together with subset-specific factors
    Roberto Baccala
    Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Immunol 174:4606-12. 2005
    ..Thus, gamma delta T cell homeostasis is maintained by trophic cytokines commonly used by other types of lymphoid cells, as well as by additional, as yet unidentified, gamma delta-specific factors...
  25. ncbi Yip1 domain family, member 6 (Yipf6) mutation induces spontaneous intestinal inflammation in mice
    Katharina Brandl
    Department of Genetics, The Scripps Research Institute, La Jolla, CA 92037, USA
    Proc Natl Acad Sci U S A 109:12650-5. 2012
    ..These studies support a tissue- and organ-specific function for Yipf6 in the maintenance of intestinal homeostasis and implicate the orthologous human gene as a disease susceptibility locus...
  26. ncbi Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus
    Roberto Baccala
    Department of Immunology and Microbial Science and Department of Genetics, The Scripps Research Institute, La Jolla, CA 92037
    Proc Natl Acad Sci U S A 110:2940-5. 2013
    ..Thus, IRF8 and SLC15A4 may provide important targets for therapeutic intervention in human lupus...
  27. ncbi Interferons as pathogenic effectors in autoimmunity
    Roberto Baccala
    Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA
    Immunol Rev 204:9-26. 2005
    ....
  28. ncbi Transmethylation in immunity and autoimmunity
    Brian R Lawson
    The Scripps Research Institute, Department of Immunology and Microbial Science, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
    Clin Immunol 143:8-21. 2012
    ..Further work in defining methylation effects in the immune system is likely to lead to a more detailed understanding of the immune system and may point to the development of novel therapeutic approaches...
  29. ncbi The new paradigm of T-cell homeostatic proliferation-induced autoimmunity
    Roberto Baccala
    Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
    Trends Immunol 26:5-8. 2005
    ..A recent study in a diabetes-prone mouse model has provided strong evidence to support this hypothesis...
  30. ncbi Contribution of histidine-rich glycoprotein in clearance of immune complexes and apoptotic cells: implications for ameliorating autoimmune diseases
    Nick N Gorgani
    Department of Immunology IMM3, The Scripps Research Institut, La Jolla, CA 92037, USA
    Autoimmunity 40:260-6. 2007
    ..Properties of HRG and possible protective actions of HRG-dependent clearance mechanisms are discussed...
  31. ncbi Genetics of SLE in mice
    Dwight H Kono
    Department of Immunology IMM3, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037, USA
    Springer Semin Immunopathol 28:83-96. 2006
    ..Mouse models of lupus should continue to serve as a vital approach to defining the genetics of SLE...
  32. ncbi Genetic complementation in female (BXSB x NZW)F2 mice
    Dwight H Kono
    Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Immunol 171:6442-7. 2003
    ....
  33. ncbi Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger
    Ben A Croker
    Department of Genetics, The Scripps Research Institute, 10550 N Torrey Pines Road, La Jolla, CA 92037, USA
    Proc Natl Acad Sci U S A 105:15028-33. 2008
    ..The SHP1-deficient phenotype is driven by microbes, which activate TLR signaling pathways to elicit IL-1 production. IL-1 signaling via MyD88 elicits inflammatory disease...
  34. ncbi Inhibition of transmethylation down-regulates CD4 T cell activation and curtails development of autoimmunity in a model system
    Brian R Lawson
    Diazyme Laboratories Division, General Atomics, San Diego, CA 92186, USA
    J Immunol 178:5366-74. 2007
    ..The data suggest that transmethylation is required for CD4 T cell activation, and its inhibition may be a novel approach in the treatment of multiple sclerosis, and other CD4-mediated autoimmune diseases...
  35. ncbi Deletion of p21 (WAF-1/Cip1) does not induce systemic autoimmunity in female BXSB mice
    Brian R Lawson
    Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Immunol 168:5928-32. 2002
    ....
  36. ncbi Proliferative arrest and cell cycle regulation in CD8(+)CD28(-) versus CD8(+)CD28(+) T cells
    Urban J Scheuring
    Department of Immunology, The Scripps Research Institute, La Jolla, CA, USA
    Hum Immunol 63:1000-9. 2002
    ..Defects in TCR signaling were associated with altered TCR zeta-chain phosphorylation...
  37. ncbi Histidine-rich glycoprotein binds to DNA and Fc gamma RI and potentiates the ingestion of apoptotic cells by macrophages
    Nick N Gorgani
    Department of Immunology IMM3, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Immunol 169:4745-51. 2002
    ..The findings indicate that HRG, by acting as a bridge between DNA on apoptotic cells and FcgammaRI on HMDM, is a key physiological mediator of apoptotic cell clearance by macrophages...
  38. ncbi Immune pathology associated with altered actin cytoskeleton regulation
    Dilki C Wickramarachchi
    Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA
    Autoimmunity 43:64-75. 2010
    ....
  39. ncbi Oligoclonal CD4(+) T cell expansions in lung transplant recipients with obliterative bronchiolitis
    Steven R Duncan
    Department of Immunology, Scripps Research Institute, La Jolla, CA, USA
    Am J Respir Crit Care Med 165:1439-44. 2002
    ..Furthermore, the close association of CD4(+) expansions with OB raises possibilities of development of novel diagnostic and therapeutic approaches...
  40. ncbi Thymic dendritic cells traffic to thymi of allogeneic recipients and prolong graft survival
    Steven R Duncan
    Department of Immunology, The Scripps Research Institute, La Jolla, California, USA
    J Clin Invest 109:755-64. 2002
    ....
  41. ncbi Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3
    Marie Laure Santiago-Raber
    Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland
    J Immunol 178:8195-202. 2007
    ..Identification of the underlying genetic alteration responsible for this quantitative trait locus should provide new insights into lupus-modifying genes...
  42. ncbi Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
    Edith Janssen
    Department of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA
    Immunity 24:787-99. 2006
    ....
  43. ncbi Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity
    Dirk Homann
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center Mail stop B140, P O Box 6511, Aurora, CO 80045, USA
    J Virol 80:270-80. 2006
    ..These findings have implications for the physiologic, pathological, and therapeutic regulation of costimulation...

Research Grants44

  1. TYPE I INTERFERONS IN LUPUS
    Argyrios N Theofilopoulos; Fiscal Year: 2010
    ..These studies will advance our knowledge of the mechanisms by which IFNs promote systemic autoimmunity and may contribute to the development of novel therapies for lupus and other autoimmune diseases. ..
  2. GENETIC BASIS OF SYSTEMIC AUTOIMMUNITY
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2002
    ..Findings generated from these studies, they expect, will significantly enhance efforts to define the etiopathogenesis of autoimmunity, and may lead to new approaches in the diagnosis and therapy of human SLE. ..
  3. CELL CYCLE AND APOPTOSIS GENES IN IMMUNOLOGIC SENESCENCE
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2002
    ..These studies of cell cycle and apoptosis of aged T-cells will be instrumental to defining the molecular defects associated with immunologic senescence. ..
  4. MURINE MODELS OF GENERALIZED AUTOIMMUNITY
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2001
    ..Additional studies using reciprocal adoptive transfers will test the influence of environment on generation and survival of membory T cells. ..
  5. T Cell Homeostasis in Systemic Autoimmunity
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2006
    ..These results will further define the biology of homeostatic anti-self T cell proliferation, land may provide a new paradigm for understanding autoimmune syndromes, including lupus. ..
  6. T Cell Homeostasis in Systemic Autoimmunity
    Argyrios N Theofilopoulos; Fiscal Year: 2010
    ..Aside from providing a new mechanistic concept, blockade of these mediators may constitute a novel therapeutic approach for lupus and other autoimmune diseases. ..
  7. TYPE I INTERFERONS IN LUPUS
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2009
    ..These studies will advance our knowledge of the mechanisms by which IFNs promote systemic autoimmunity and may contribute to the development of novel therapies for lupus and other autoimmune diseases. ..
  8. T Cell Homeostasis in Systemic Autoimmunity
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2009
    ..Aside from providing a new mechanistic concept, blockade of these mediators may constitute a novel therapeutic approach for lupus and other autoimmune diseases. ..
  9. GENETIC BASIS OF SYSTEMIC AUTOIMMUNITY
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2007
    ..These studies should yield significant new insights into the etiopathogenesis of systemic autoimmunity, and may lead to new diagnostic and therapeutic approaches for human SLE. ..
  10. TYPE I INTERFERONS IN LUPUS
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 2007
    ..These studies will advance our knowledge of the mechanisms by which IFNs promote systemic autoimmunity and may contribute to the development of novel therapies for lupus and other autoimmune diseases. ..
  11. MURINE MODELS OF GENERALIZED AUTOIMMUNITY
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 1990
    ....
  12. T CELL ANTIGEN RECEPTOR GENES IN AUTOIMMUNITY
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 1992
    ..Identification of aberrancies in this central event is expected to have a significant impact on our ability to molecularly define autoimmune diseases and to devise specific and accurate means for their management...
  13. GENETIC BASIS OF SYSTEMIC AUTOIMMUNITY
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 1993
    ..Creation of linkage maps and identification of pleotropic or specific autoimmune trait-associated genes will ultimately provide the means by which the molecular basis of lupus can be defined...
  14. MURINE MODELS OF GENERALIZED AUTOIMMUNITY
    ARGYRIOS THEOFILOPOULOS; Fiscal Year: 1993
    ....